Barclays’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $211K | Sell |
6,533
-809
| -11% | -$20.9K | ﹤0.01% | 3656 |
|
|
2026
Q1 | $135K | Sell |
7,342
-53,053
| -88% | -$1.01M | ﹤0.01% | 3904 |
|
|
2025
Q4 | $952K | Sell |
60,395
-256,839
| -81% | -$4.58M | ﹤0.01% | 3464 |
|
|
2025
Q3 | $6.14M | Sell |
317,234
-324,096
| -51% | -$6.33M | ﹤0.01% | 2037 |
|
|
2025
Q2 | $13.3M | Buy |
641,330
+264,242
| +70% | +$5.49M | ﹤0.01% | 1375 |
|
|
2025
Q1 | $9.22M | Buy |
377,088
+180,449
| +92% | +$4.63M | ﹤0.01% | 1468 |
|
|
2024
Q4 | $4.7M | Buy |
196,639
+104,838
| +114% | +$3.33M | ﹤0.01% | 2219 |
|
|
2024
Q3 | $3.89M | Buy |
91,801
+67,595
| +279% | +$3.54M | ﹤0.01% | 2293 |
|
|
2024
Q2 | $1.24M | Sell |
24,206
-10,369
| -30% | -$588K | ﹤0.01% | 2472 |
|
|
2024
Q1 | $2.16M | Sell |
34,575
-76,815
| -69% | -$5.23M | ﹤0.01% | 2494 |
|
|
2023
Q4 | $8.34M | Buy |
111,390
+68,062
| +157% | +$4.87M | ﹤0.01% | 1652 |
|
|
2023
Q3 | $3.69M | Sell |
43,328
-20,463
| -32% | -$1.94M | ﹤0.01% | 1514 |
|
|
2023
Q2 | $6.96M | Buy |
63,791
+17,165
| +37% | +$1.63M | ﹤0.01% | 1154 |
|
|
2023
Q1 | $3.87M | Buy |
46,626
+11,148
| +31% | +$1.05M | ﹤0.01% | 1724 |
|
|
2022
Q4 | $3.65M | Buy |
35,478
+132
| +0.4% | +$15.2K | ﹤0.01% | 1849 |
|
|
2022
Q3 | $3.75M | Sell |
35,346
-11,627
| -25% | -$1.27M | ﹤0.01% | 1340 |
|
|
2022
Q2 | $5.15M | Sell |
46,973
-9,799
| -17% | -$970K | ﹤0.01% | 1317 |
|
|
2022
Q1 | $5.92M | Sell |
56,772
-9,598
| -14% | -$996K | ﹤0.01% | 1149 |
|
|
2021
Q4 | $8.12M | Buy |
66,370
+20,415
| +44% | +$2.27M | ﹤0.01% | 1387 |
|
|
2021
Q3 | $5.27M | Buy |
45,955
+16,685
| +57% | +$1.77M | ﹤0.01% | 1605 |
|
|
2021
Q2 | $2.84M | Sell |
29,270
-35,469
| -55% | -$3.08M | ﹤0.01% | 1952 |
|
|
2021
Q1 | $4.77M | Sell |
64,739
-1,731
| -3% | -$129K | ﹤0.01% | 1556 |
|
|
2020
Q4 | $4.54M | Sell |
66,470
-3,054
| -4% | -$199K | ﹤0.01% | 1575 |
|
|
2020
Q3 | $4.06M | Sell |
69,524
-24,185
| -26% | -$1.27M | ﹤0.01% | 1533 |
|
|
2020
Q2 | $4.24M | Buy |
93,709
+4,855
| +5% | +$232K | ﹤0.01% | 1501 |
|
|
2020
Q1 | $5.14M | Buy |
88,854
+4,725
| +6% | +$323K | ﹤0.01% | 1443 |
|
|
2019
Q4 | $5.24M | Buy |
84,129
+21,653
| +35% | +$1.28M | ﹤0.01% | 1950 |
|
|
2019
Q3 | $3.6M | Buy |
62,476
+6,975
| +13% | +$386K | ﹤0.01% | 2178 |
|
|
2019
Q2 | $3.01M | Sell |
55,501
-2,093
| -4% | -$106K | ﹤0.01% | 2434 |
|
|
2019
Q1 | $2.71M | Buy |
57,594
+15,090
| +36% | +$837K | ﹤0.01% | 2250 |
|
|
2018
Q4 | $2.41M | Sell |
42,504
-29,182
| -41% | -$1.64M | ﹤0.01% | 2226 |
|
|
2018
Q3 | $3.92M | Buy |
71,686
+28,696
| +67% | +$1.64M | ﹤0.01% | 2069 |
|
|
2018
Q2 | $2.52M | Buy |
42,990
+24,350
| +131% | +$1.45M | ﹤0.01% | 2348 |
|
|
2018
Q1 | $1.06M | Buy |
18,640
+8,137
| +77% | +$442K | ﹤0.01% | 3146 |
|
|
2017
Q4 | $519K | Buy |
10,503
+8,900
| +555% | +$406K | ﹤0.01% | 3788 |
|
|
2017
Q3 | $73K | Sell |
1,603
-5,500
| -77% | -$210K | ﹤0.01% | 5139 |
|
|
2017
Q2 | $277K | Buy |
7,103
+2,051
| +41% | +$78.7K | ﹤0.01% | 4084 |
|
|
2017
Q1 | $204K | Sell |
5,052
-122,800
| -96% | -$4.81M | ﹤0.01% | 4298 |
|
|
2016
Q4 | $4.92M | Buy |
127,852
+37,490
| +41% | +$1.28M | 0.01% | 1382 |
|
|
2016
Q3 | $2.88M | Buy |
90,362
+3,533
| +4% | +$134K | ﹤0.01% | 1704 |
|
|
2016
Q2 | $3.47M | Sell |
86,829
-164
| -0.2% | -$6.07K | ﹤0.01% | 1576 |
|
|
2016
Q1 | $2.87M | Buy |
86,993
+20,093
| +30% | +$575K | ﹤0.01% | 1629 |
|
|
2015
Q4 | $2.07M | Buy |
66,900
+66,652
| +26,876% | +$1.97M | ﹤0.01% | 2005 |
|
|
2015
Q3 | $7K | Sell |
248
-662
| -73% | -$21.8K | ﹤0.01% | 5906 |
|
|
2015
Q2 | $28K | Sell |
910
-487
| -35% | -$12.7K | ﹤0.01% | 5481 |
|
|
2015
Q1 | $31K | Sell |
1,397
-1,252
| -47% | -$25.9K | ﹤0.01% | 5594 |
|
|
2014
Q4 | $50K | Buy |
2,649
+1,018
| +62% | +$17.5K | ﹤0.01% | 5708 |
|
|
2014
Q3 | $24K | Sell |
1,631
-10,044
| -86% | -$143K | ﹤0.01% | 6366 |
|
|
2014
Q2 | $140K | Sell |
11,675
-1,605
| -12% | -$19.2K | ﹤0.01% | 5158 |
|
|
2014
Q1 | $172K | Sell |
13,280
-10,182
| -43% | -$147K | ﹤0.01% | 4925 |
|
|
2013
Q4 | $329K | Sell |
23,462
-9,613
| -29% | -$130K | ﹤0.01% | 4507 |
|
|
2013
Q3 | $430K | Sell |
33,075
-9,673
| -23% | -$142K | ﹤0.01% | 4278 |
|
|
2013
Q2 | $613K | Buy |
+42,748
| New | +$600K | ﹤0.01% | 3973 |
|
Other funds holding AMN
Barclays's AMN Position: Q2 2026 in Review
Barclays reduced its AMN Healthcare (AMN) stake by 11% in Q2 2026, selling an estimated $20.9K and leaving 6,533 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #3656.
Barclays first reported a position in AMN in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.3M in Q2 2025. 284 funds tracked by Wall St. Rank hold AMN as of Q2 2026.
- Barclays held 6,533 shares of AMN Healthcare worth $211K as of Q2 2026.
- Barclays sold 809 AMN Healthcare shares in Q2 2026, an estimated $20.9K.
- AMN Healthcare made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3656 holding.
- Barclays first reported a position in AMN Healthcare in Q2 2013 and has held it in 53 quarters since.
- Barclays's AMN Healthcare position peaked at $13.3M in Q2 2025.
- 284 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.